CN102793747A - Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis - Google Patents

Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis Download PDF

Info

Publication number
CN102793747A
CN102793747A CN2011101357563A CN201110135756A CN102793747A CN 102793747 A CN102793747 A CN 102793747A CN 2011101357563 A CN2011101357563 A CN 2011101357563A CN 201110135756 A CN201110135756 A CN 201110135756A CN 102793747 A CN102793747 A CN 102793747A
Authority
CN
China
Prior art keywords
parts
chinese medicinal
chronic rhinitis
angelicae dahuricae
angelica dahurica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011101357563A
Other languages
Chinese (zh)
Inventor
张艳忠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011101357563A priority Critical patent/CN102793747A/en
Publication of CN102793747A publication Critical patent/CN102793747A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis. The Chinese medicinal magnolia flower and angelica dahurica powder comprises the following Chinese medicinal components in part by weight: 14 to 16 parts of magnolia flower, 29 to 31 parts of angelica dahurica, 14 to 16 parts of mint and 6 to 8 parts of siberian cocklour fruit (fried). The common pure Chinese medicines are taken as components, and are reasonably compatible; the Chinese medicinal magnolia flower and angelica dahurica powder does not have toxic or side effects, and is convenient to use; and when the powder is orally taken, an optimal effect can be achieved.

Description

A kind of Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treating chronic rhinitis looses
Technical field
The invention belongs to the Chinese medicine technical field of pharmaceuticals, especially a kind of Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treating chronic rhinitis looses.
Background technology
Chronic rhinitis is the nonspecific inflammation of bronchia mucosal and Submucosa more than the lasting several months, or inflammation shows effect repeatedly, and Submucosa also can not recover normal person in the phase of gap.Clinical in persistence or intermittence, property nasal obstruction alternately, nasal mucus increases and is characteristic.Primary disease is many thoroughly not to be developed, develops and cause because of the acute rhinitis treatment.Be divided into chronic simple rhinitis and chronic hypertrophic rhinitis clinically.Its clinical manifestation is:
Chronic simple rhinitis:
Nasal obstruction is intermittent or property alternately, generally by day, movable back nasal obstruction alleviates or disappear; Night, sat quietly for a long time, tired, meet that nasal obstruction increases the weight of when cold.When lying on one's side, the upside nasal airflow is good, the downside congestion.Mostly nasal mucus is mucus.The congested swelling of nasal mucosa is seen in inspection, is main with concha nasalis inferior, smooth surface, that touches is flexible, caves in the mucosa that can make of probe pressures, remove probe after recess can calm down very soon.Responsive to vasoconstrictor response.
Hypertrophic rhinitis:
Nasal obstruction is persistence, and rhinophonia is heavier, and hyposmia is obvious, and the nasal mucus amount is few and glutinous, is difficult for blowing out.The visible bronchia mucosal of inspection is kermesinus or pale asphyxia, and the concha nasalis hypertrophy is loose, and performance is uneven, and is nodal-like or Fructus Mori appearance, and the poor flexibility of touching with the depression that is difficult for of probe pressures, removes that depression is difficult behind the probe calms down very soon.Insensitive to vasoconstrictor response.The Therapeutic Principle of primary disease recovers the nasal airflow function for eradicating the cause of disease, removes secretions.
The traditional Chinese medical science claims that primary disease is " stuffy nose ", is mostly evil stagnant, the caused by energy stagnation and blood stasis of the deficiency of the lung.Chronic rhinitis has intractable and recurrent characteristics, and common Western medicine is all cured the symptoms, not the disease, and is difficult to it is thoroughly eradicated.
Therefore, need a kind of Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of new treatment chronic rhinitis to loose with better treatment chronic rhinitis.
Summary of the invention
In view of this, the present invention is devoted to better to treat chronic rhinitis, has proposed a kind of Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treating chronic rhinitis and has loose.
According to technical scheme of the present invention, provide a kind of Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treating chronic rhinitis to loose.The Chinese medicinal components that following weight ratio is formed is drawn together in this Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae Bales Off: Flos Magnoliae 14-16 part, Radix Angelicae Dahuricae 29-31 part, Herba Menthae 14-16 part, Fructus Xanthii (parched) 6-8 part.Its best main being divided into: 15 parts of Flos Magnoliaes, 30 parts of the Radixs Angelicae Dahuricae, 15 parts of Herba Menthaes, 7 parts of Fructus Xanthii (parched)s.
Use usage:
The Chinese medicine of said components ratio is ground into smalls.Day obeys 2 times, each 6g, and children's is cut down according to the circumstance.Sooner or later respectively once.10 days is a course of treatment, and take effect a course of treatment, and can eradicate 3 courses of treatment.Food, Semen phaseoli radiati, green tea etc. avoid pungent food during the medication.
Among the present invention, Flos Magnoliae: dispel the wind, sensible, control headache, nasal sinusitis, it is obstructed to have a stuffy nose, toothache.The Radix Angelicae Dahuricae: dispel the wind dampness, detumescence, pain relieving.Fructus Xanthii: dispersing wind and cold; Clearing the nasal passage; Wind-damp dispelling; Antipruritic.Herba Menthae: dispelling wind, the heat radiation, ward off dirty, the detoxifcation.
The present invention treats the diffusing expelling wind and cold of the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of chronic rhinitis, and reducing swelling and alleviating pain improves the internal medium of nose and repairs the nasal membrane tissue that pathological changes takes place.Be applicable to common rhinitis etc., life-time service has the elimination effect to the intractable chronic rhinitis.
Through the result that clinical 200 examples are used, cure rate reaches 93.7%, and (recovery from illness: nasal airflow is good, and secretions reduces; The nasal conchae hypertrophy situation is thoroughly improved; The headache situation that occurs together disappears), the improver reaches 4% (improver: more preceding ventilation has improvement and secretions to reduce, but does not see normal fully).
Clinical practice instance of the present invention is following:
Instance one, Zhang Gang, the man, 35 years old, black rich people from Shizhong District suffered from surplus the chronic rhinitis 10 year, long-term nasal obstruction, watery nasal discharge, the concha nasalis enlargement, intermittent headache occurs together.It is for oral administration to use the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of the present invention to loose, and take effect 1 course of treatment, and thoroughly eradicate 3 courses of treatment, and concha nasalis recovers original size, and not recurrence in 3 years.
Instance two, Lin Li, the woman, 44 years old, Accessories during Binzhou people suffered from chronic rhinitis 7 years, during cold and hot season alternation, sneeze often, the situation aggravation does not have olfactory sensation fully when getting angry, and the nose ventilation is not smooth.Use the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of the present invention to loose, for oral administration 1 the course of treatment sx, removed symptom 2 courses of treatment, under the doctor advises, takes the 3rd course of treatment, rhinitis is not recommitted so far.
Instance three, Zhang Huankang, the man, 4 years old, people from Jining City, caught a cold from 2 years old chronic rhinitis, when outbreak, adopt intranasal to splash into vasoconstrictor usually, can improve the ventilation and the drain of nasal cavity like 1% ephedrine etc., inflammation is disappeared, but but outbreak often.Use the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of the present invention to loose, 1 course of treatment for oral administration, nasal discharge obviously reduces, and inspection sees that the congested situation of nasal mucosa is eased, use 3 courses of treatment after, symptom is thoroughly eliminated, and does not have recurrence so far.
Instance four, Wang Haijun, the man, 45 years old, the office worker of Jinan statistics bureau suffered from chronic rhinitis 5 years.Because intranasal hamartoplasia, mucomembranous surface is uneven, and concha nasalis inferior is the Fructus Mori shape to be changed, and the middle nasal concha mucosa is polypoid and becomes, hypopnea, olfactory sensation completely without.Take the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of the present invention and loose 1 course of treatment, breath state is eased, and after 2 courses of treatment, olfactory sensation part gradually recovers, and it is smooth that nasal mucosa begins to become, and after 3 courses of treatment, olfactory sensation recovers, and the concha nasalis inferior reinstatement, and the middle nasal concha polyp disappears.
Instance five, Xue Liping, the woman, 31 years old, the Chengbei District people of Qingdao City suffered from chronic rhinitis 10 years.Forehead pain is lain awake all night unbearably when serious, and it is obstructed to have a stuffy nose, and intracavity has the pus point, and purulent secretion is arranged, and once accepts puncture for treating, and effect is not ideal enough, often recurrence.After take the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of the present invention and loose 1 course of treatment, nasal cavity purulence thing reduces, ventilation makes moderate progress.Again through the treatments of 2 courses of treatment, the rhinitis transference cure, its headache that occurs together does not occur yet, not recurrence in 2 years.
The invention has the beneficial effects as follows:
The present invention adopts Chinese medicine preparation, and side effect is little, simultaneously, only can thoroughly be eradicated through taking medicine of certain course of treatment the intractable chronic rhinitis, and expense is relatively also low.
The specific embodiment
In order better to treat chronic rhinitis, the invention provides a kind of Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treating chronic rhinitis and loose.Next combine embodiment to specify the Chinese medicine Magnoliae Powder of this treatment chronic rhinitis.
Embodiment one
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 14 parts of Flos Magnoliaes, 29 parts of the Radixs Angelicae Dahuricae, 14 parts of Herba Menthaes, 6 parts of Fructus Xanthii (stir-fry).The Chinese medicine of said components ratio is ground into smalls.
Embodiment two
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 15 parts of Flos Magnoliaes, 30 parts of the Radixs Angelicae Dahuricae, 15 parts of Herba Menthaes, 7 parts of Fructus Xanthii (stir-fry).The Chinese medicine of said components ratio is ground into smalls.
Embodiment three
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 15 parts of Flos Magnoliaes, 30 parts of the Radixs Angelicae Dahuricae, 15 parts of Herba Menthaes, 6 parts of Fructus Xanthii (stir-fry).The Chinese medicine of said components ratio is ground into smalls.
Embodiment four
Chinese medicine Magnoliae Powder of the present invention comprises the Chinese medicinal components that following weight ratio is formed: 16 parts of Flos Magnoliaes, 31 parts of the Radixs Angelicae Dahuricae, 16 parts of Herba Menthaes, 8 parts of Fructus Xanthii (stir-fry).The Chinese medicine of said components ratio is ground into smalls.
More than be the implementation that specific descriptions of the present invention are intended to explain specific embodiments, can not be interpreted as it is limitation of the present invention.Those of ordinary skills can make various variants on the basis of the embodiment that details under instruction of the present invention, these variants all should be included within the design of the present invention.The present invention's scope required for protection is only limited by described claims.

Claims (2)

1. a Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treating chronic rhinitis looses, and it is characterized in that: comprise the Chinese medicinal components that following weight ratio is formed: Flos Magnoliae 14-16 part, Radix Angelicae Dahuricae 29-31 part, Herba Menthae 14-16 part, Fructus Xanthii (stir-fry) 6-8 part.
2. the Chinese medicine Flos Magnoliae Radix Angelicae Dahuricae of treatment chronic rhinitis as claimed in claim 1 looses, and it is characterized in that: comprise the Chinese medicinal components that following weight ratio is formed: 15 parts of Flos Magnoliaes, 30 parts of the Radixs Angelicae Dahuricae, 15 parts of Herba Menthaes, 7 parts of Fructus Xanthii (stir-fry).
CN2011101357563A 2011-05-25 2011-05-25 Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis Pending CN102793747A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101357563A CN102793747A (en) 2011-05-25 2011-05-25 Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101357563A CN102793747A (en) 2011-05-25 2011-05-25 Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis

Publications (1)

Publication Number Publication Date
CN102793747A true CN102793747A (en) 2012-11-28

Family

ID=47193216

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101357563A Pending CN102793747A (en) 2011-05-25 2011-05-25 Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis

Country Status (1)

Country Link
CN (1) CN102793747A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104523839A (en) * 2014-12-12 2015-04-22 訾璐 Medicine for treating rhinitis
CN104740217A (en) * 2015-04-17 2015-07-01 青岛辰达生物科技有限公司 Traditional Chinese medicinal composition for treating rhinitis and preparation method thereof
CN105748609A (en) * 2016-03-12 2016-07-13 吴申龙 Traditional Chinese medicine composition for treating chronic rhinitis and preparation method and application thereof
CN106620209A (en) * 2015-11-03 2017-05-10 朱元玉 Medicine for treating rhinitis
CN107334817A (en) * 2017-06-30 2017-11-10 郑州澍青医学高等专科学校 A kind of Chinese medicine for treating nasosinusitis
CN108619241A (en) * 2018-06-20 2018-10-09 刘永利 Antiallergic multifunction invisible mask
CN112156131A (en) * 2020-11-10 2021-01-01 天津中医药大学 Mask for treating rhinitis and preparation method
CN112870256A (en) * 2021-03-11 2021-06-01 海南善济堂中医研究院有限公司 Traditional Chinese medicine composition for treating rhinitis
CN113967193A (en) * 2020-07-23 2022-01-25 段育梁 Water-based spray for treating rhinitis

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104523839A (en) * 2014-12-12 2015-04-22 訾璐 Medicine for treating rhinitis
CN104740217A (en) * 2015-04-17 2015-07-01 青岛辰达生物科技有限公司 Traditional Chinese medicinal composition for treating rhinitis and preparation method thereof
CN106620209A (en) * 2015-11-03 2017-05-10 朱元玉 Medicine for treating rhinitis
CN105748609A (en) * 2016-03-12 2016-07-13 吴申龙 Traditional Chinese medicine composition for treating chronic rhinitis and preparation method and application thereof
CN107334817A (en) * 2017-06-30 2017-11-10 郑州澍青医学高等专科学校 A kind of Chinese medicine for treating nasosinusitis
CN108619241A (en) * 2018-06-20 2018-10-09 刘永利 Antiallergic multifunction invisible mask
CN113967193A (en) * 2020-07-23 2022-01-25 段育梁 Water-based spray for treating rhinitis
CN112156131A (en) * 2020-11-10 2021-01-01 天津中医药大学 Mask for treating rhinitis and preparation method
CN112156131B (en) * 2020-11-10 2022-01-28 天津中医药大学 Mask for treating rhinitis and preparation method
CN112870256A (en) * 2021-03-11 2021-06-01 海南善济堂中医研究院有限公司 Traditional Chinese medicine composition for treating rhinitis

Similar Documents

Publication Publication Date Title
CN102793747A (en) Chinese medicinal magnolia flower and angelica dahurica powder for treating chronic rhinitis
CN101987190A (en) Traditional Chinese medicine for efficiently treating rhinitis
CN103356792B (en) Chinese medicine composition for treating chronic rhinitis
CN103463416A (en) Traditional Chinese medicine preparation for treating rhinitis and pharyngitis
CN101979022A (en) Chinese medicinal mixture for treating chronic rhinitis
CN102895313B (en) Traditional Chinese medicine composition for treating diseases of ophthalmology and otorhinolaryngology
CN102451238B (en) Chinese medicinal preparation for treating rhinitis
CN102614306A (en) Traditional Chinese herbal preparation for treating chronic nasosinusitis
CN103330853B (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN101773601B (en) Throat-care granules in bag for treatment of pharyngitis
CN103893266A (en) Traditional Chinese medicine used for treating nasal obstruction
CN103285169A (en) Traditional Chinese medicine pill for treatment of chronic rhinitis
CN102793735A (en) Chinese medicinal angelica dahurica powder for treating chronic rhinitis
CN101670050B (en) Traditional Chinese medicine composition for treating chronic pharyngitis
CN102441033A (en) Chinese medicine magnolia flower powder for treating chronic rhinitis
CN104706789A (en) Traditional Chinese medicine for treating chronic suppurative otitis media
CN101095824A (en) Pharynx-cleaning detoxicating capsule
CN101804182B (en) Traditional Chinese medicine prescription for treating nasal sinusitis
CN102697894B (en) Medicinal composition for treating nasal cavity inflammatory disease and preparation method thereof
CN103272130B (en) Preparation method of traditional Chinese medicine for treating chronic nasosinusitis by machine
CN103223091B (en) Traditional Chinese medicinal composition for treating chronic pharyngitis
CN101732584B (en) Throat disinhibiting bagged soaking preparation for treating pharyngitis
CN105641463A (en) Traditional Chinese medicine for treating interstitial cystitis
CN105125880A (en) Traditional Chinese medicine for treating chronic tonsillitis
CN104161854A (en) Traditional Chinese medicine for treating rhinitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121128